Literature DB >> 19830690

Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon.

Masahiko Tanaka1,2, Takashi Shimbo1, Yasushi Kikuchi1, Masahide Matsuda1,3, Yasufumi Kaneda1.   

Abstract

Malignant glioma is one of the most aggressive cancers. For the development of effective therapeutic strategies against such malignant diseases, elucidation of molecular targets is necessary. We found that inactivated Sendai virus particle (HVJ-E) induced extensive cell death in the human glioblastoma cell line U251MG. Intradermal U251MG tumors were more effectively suppressed by HVJ-E than interferon (IFN)-beta. From microarray analysis of gene expression in U251MG cells treated with HVJ-E, we focused on the up-regulation of sterile alpha motif containing domain 9 (SAMD9) gene. The expression of the SAMD9 gene was induced by administration of recombinant human IFN-alpha, -beta or -gamma. The up-regulation of the SAMD9 gene by HVJ-E treatment was abrogated by IFN receptor blocking antibody or JAK inhibitor treatment. When SAMD9 expression was knocked down by RNA interference, apoptotic cell death induced by HVJ-E was blocked in U251MG cells. Suppression of SAMD9 using SAMD9 siRNA also inhibited IFN-beta-induced death in U251MG cells with a small, but significant, difference to control groups. However, overexpression of the SAMD9 gene failed to induce significant cell death in U251MG cells. Thus, SAMD9 could be a key molecule to control cancer cell death by HVJ-E or IFN-beta treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19830690     DOI: 10.1002/ijc.24965

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.

Authors:  Kazuyuki Matsushita; Hideaki Shimada; Yasuji Ueda; Makoto Inoue; Mamoru Hasegawa; Takeshi Tomonaga; Hisahiro Matsubara; Fumio Nomura
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  The Samd9L gene: transcriptional regulation and tissue-specific expression in mouse development.

Authors:  Qiujie Jiang; Benjamin Quaynor; Alex Sun; Qiaoli Li; Hirotaka Matsui; Hiroaki Honda; Toshiya Inaba; Eli Sprecher; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2011-03-17       Impact factor: 8.551

3.  C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1.

Authors:  Xiangzhi Meng; John Schoggins; Lloyd Rose; Jingxin Cao; Alexander Ploss; Charles M Rice; Yan Xiang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Homeobox B8 Targets Sterile Alpha Motif Domain-Containing Protein 9 and Drives Glioma Progression.

Authors:  Wenping Ma; Hongze Jin; Wenjie Liu; Xiaojuan Li; Xingang Zhou; Xinwu Guo; Runfa Tian; Qi Cui; Junjie Luo; Yueying Jiao; Youtao Yu; Haifeng Yang; Hongshan Zhao
Journal:  Neurosci Bull       Date:  2019-10-23       Impact factor: 5.203

5.  Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.

Authors:  Masahide Matsuda; Keisuke Nimura; Takashi Shimbo; Toshimitsu Hamasaki; Tetsuya Yamamoto; Akira Matsumura; Yasufumi Kaneda
Journal:  J Neurooncol       Date:  2010-08-22       Impact factor: 4.130

6.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.

Authors:  Dov Hershkovitz; Yonit Gross; Sagi Nahum; Shiran Yehezkel; Ofer Sarig; Jouni Uitto; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

7.  Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins.

Authors:  Xiangzhi Meng; Brian Krumm; Yongchao Li; Junpeng Deng; Yan Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

8.  Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma.

Authors:  Takashi Shimbo; Atsushi Tanemura; Takehiko Yamazaki; Katsuto Tamai; Ichiro Katayama; Yasufumi Kaneda
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

9.  SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7.

Authors:  Satoshi Narumi; Naoko Amano; Tomohiro Ishii; Noriyuki Katsumata; Koji Muroya; Masanori Adachi; Katsuaki Toyoshima; Yukichi Tanaka; Ryuji Fukuzawa; Kenichi Miyako; Saori Kinjo; Shouichi Ohga; Kenji Ihara; Hirosuke Inoue; Tadamune Kinjo; Toshiro Hara; Miyuki Kohno; Shiro Yamada; Hironaka Urano; Yosuke Kitagawa; Koji Tsugawa; Asumi Higa; Masakazu Miyawaki; Takahiro Okutani; Zenro Kizaki; Hiroyuki Hamada; Minako Kihara; Kentaro Shiga; Tetsuya Yamaguchi; Manabu Kenmochi; Hiroyuki Kitajima; Maki Fukami; Atsushi Shimizu; Jun Kudoh; Shinsuke Shibata; Hideyuki Okano; Noriko Miyake; Naomichi Matsumoto; Tomonobu Hasegawa
Journal:  Nat Genet       Date:  2016-05-16       Impact factor: 38.330

10.  RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.

Authors:  Marie K Kirby; Ryne C Ramaker; Jason Gertz; Nicholas S Davis; Bobbi E Johnston; Patsy G Oliver; Katherine C Sexton; Edward W Greeno; John D Christein; Martin J Heslin; James A Posey; William E Grizzle; Selwyn M Vickers; Donald J Buchsbaum; Sara J Cooper; Richard M Myers
Journal:  Mol Oncol       Date:  2016-05-26       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.